Holocene Advisors’s Hims & Hers Health HIMS Stock Holding History

Holocene Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Sell	38,962 -544,212	-93%	-$14.6M	﹤0.01%	642
2026 Q1	$12.1M	Buy	+583,174	New	+$13.8M	0.03%	308
2023 Q2	–	Sell	-48,464	Closed	-$481K	–	776
2023 Q1	$481K	Buy	+48,464	New	+$425K	﹤0.01%	651
2022 Q2	–	Sell	-23,764	Closed	-$127K	–	900
2022 Q1	$127K	Sell	23,764 -282,736	-92%	-$1.4M	﹤0.01%	846
2021 Q4	$2.01M	Buy	306,500 +47,282	+18%	+$342K	0.01%	537
2021 Q3	$1.96M	Buy	259,218 +219,635	+555%	+$1.86M	0.01%	561
2021 Q2	$431K	Buy	+39,583	New	+$471K	﹤0.01%	757

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Holocene Advisors's HIMS Position: Q2 2026 in Review

Holocene Advisors reduced its Hims & Hers Health (HIMS) stake by 93% in Q2 2026, selling an estimated $14.6M and leaving 38,962 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Holocene Advisors first reported a position in HIMS in Q2 2021 and has held it in 7 quarters since. The position peaked at $12.1M in Q1 2026. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Holocene Advisors held 38,962 shares of Hims & Hers Health worth $1.35M as of Q2 2026.
Holocene Advisors sold 544,212 Hims & Hers Health shares in Q2 2026, an estimated $14.6M.
Hims & Hers Health made up ﹤0.01% of Holocene Advisors's portfolio in Q2 2026, its #642 holding.
Holocene Advisors first reported a position in Hims & Hers Health in Q2 2021 and has held it in 7 quarters since.
Holocene Advisors's Hims & Hers Health position peaked at $12.1M in Q1 2026.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.